Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Investigational New Drugs
|
July 1, 1992
Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer
J A Benvenuto, R A Newman, G S Bignami, et al.
Investigational New Drugs
|
July 1, 1989
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity
J L Abbruzzese, S Schmidt, M N Raber, et al.
Cancer Research
|
July 15, 1990
Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II)
R Perez-Soler, G Lopez-Berestein, J Lautersztain, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1992
Clinical pharmacology of combined oral uracil and ftorafur
D H Ho, W P Covington, R Pazdur, et al.
Cancer Research
|
September 1, 1983
Flow cytometry in clinical cancer research
B Barlogie, M N Raber, J Schumann, et al.
Investigational New Drugs
|
November 1, 1991
Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma
F V Fossella, R J Winn, P Y Holoye, et al.
Investigational New Drugs
|
January 1, 1994
Phase II clinical trial of didemnin B in previously treated small cell lung cancer
D M Shin, P Y Holoye, A Forman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1995
Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors
J S Lee, R A Newman, S M Lippman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1993
Phase I evaluation of all-trans-retinoic acid in adults with solid tumors
J S Lee, R A Newman, S M Lippman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1991
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine
J L Abbruzzese, R Grunewald, E A Weeks, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Investigational New Drugs
|
July 1, 1992
Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer
J A Benvenuto, R A Newman, G S Bignami, et al.
Investigational New Drugs
|
July 1, 1989
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity
J L Abbruzzese, S Schmidt, M N Raber, et al.
Cancer Research
|
July 15, 1990
Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II)
R Perez-Soler, G Lopez-Berestein, J Lautersztain, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1992
Clinical pharmacology of combined oral uracil and ftorafur
D H Ho, W P Covington, R Pazdur, et al.
Cancer Research
|
September 1, 1983
Flow cytometry in clinical cancer research
B Barlogie, M N Raber, J Schumann, et al.
Investigational New Drugs
|
November 1, 1991
Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma
F V Fossella, R J Winn, P Y Holoye, et al.
Investigational New Drugs
|
January 1, 1994
Phase II clinical trial of didemnin B in previously treated small cell lung cancer
D M Shin, P Y Holoye, A Forman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1995
Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors
J S Lee, R A Newman, S M Lippman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1993
Phase I evaluation of all-trans-retinoic acid in adults with solid tumors
J S Lee, R A Newman, S M Lippman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1991
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine
J L Abbruzzese, R Grunewald, E A Weeks, et al.
Page
of 6